VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

iBio, Inc. (IBIO) Total Return Calculator with Dividends Reinvested

iBio, Inc.

Popular:

The total return for iBio, Inc. (IBIO) stock is +92.94% over the past 12 months. So far it's down 18.81% this year. The 5-year total return is -99.80%, meaning $10,000 invested in IBIO stock 5 years ago would be worth $20 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in IBIO 1 year ago, it would be worth $19,759 today — you'd have gained $9,759.

With Dividends Reinvested$19,759+97.59%

Price Only (No DRIP)$19,759+97.59%

Period2025-05-08 → 2026-05-07

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in IBIO

1Y$19,294+$9,294 (+92.9%)92.9% CAGR

3Y$759-$9,241 (-92.4%)-57.7% CAGR

5Y$20-$9,980 (-99.8%)-71.0% CAGR

10Y$5-$9,995 (-100.0%)-53.5% CAGR

15Y$1-$9,999 (-100.0%)-45.3% CAGR

20Y$3-$9,997 (-100.0%)-32.9% CAGR

30Y$3-$9,997 (-100.0%)-23.3% CAGR

iBio, Inc. did not pay dividends during this period. Total return = price return.

Loading IBIO total return...

As of 2026-05-08

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-18.81%	—	-18.81%	—	$8,119
1Y	+92.94%	92.94%	+92.94%	—	$19,294
3Y	-92.41%	-57.66%	-92.41%	—	$759
5Y	-99.80%	-71.04%	-99.80%	—	$20
10Y	-99.95%	-53.48%	-99.95%	—	$5
15Y	-99.99%	-45.31%	-99.99%	—	$1
20Y	-99.97%	-32.87%	-99.97%	—	$3
30Y	-99.97%	-23.34%	-99.97%	—	$3

Risk & Highlights

Best Year+650.00%2009

Worst Year-97.11%2022

Max Drawdown-48.21%2026-02-26 → 2026-05-04

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	+39.60%	+39.60%	—	+0.41%	+39.2pp
2025	-20.25%	-20.25%	—	+16.64%	-36.9pp
2024	+77.54%	+77.54%	—	+24.00%	+53.5pp
2023	-89.62%	-89.62%	—	+24.81%	-114.4pp
2022	-97.11%	-97.11%	—	-19.95%	-77.2pp

IBIO outperformed the S&P 500 by 62.57pp over the past year (+92.94% vs +30.37%).

Loading summary...

IBIO Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
IBIOiBio, Inc.	$26M	-22.3%	-18.8%	+92.9%	—	-92.4%	-99.8%	-100.0%
IMVTImmunovant, Inc.	$5.5B	+10.6%	+5.1%	+96.1%	—	+40.9%	+62.4%	+173.6%
ADMAADMA Biologics, Inc.	$2.0B	-8.5%	-52.6%	-64.1%	—	+142.0%	+386.8%	+39.8%
HALOHalozyme Therapeutics, Inc.	$7.7B	+2.5%	-7.3%	-7.1%	—	+115.3%	+37.0%	+570.7%
AKROAkero Therapeutics, Inc.	$4.5B	—	—	+27.7%	—	+20.1%	+100.0%	+198.3%
NVAXNovavax, Inc.	$1.5B	+15.7%	+29.5%	+55.1%	—	+23.9%	-94.8%	-90.4%
DYAIDyadic International, Inc.	$27M	-19.0%	-20.7%	-31.7%	—	-57.4%	-82.1%	-56.4%
ABCLAbCellera Biologics Inc.	$1.4B	+46.1%	+40.5%	+139.8%	—	-15.6%	-83.4%	-91.8%
RCKTRocket Pharmaceuticals, Inc.	$398M	+5.5%	+6.1%	-45.2%	—	-82.8%	-91.6%	-91.3%
XOMAXOMA Royalty Corp.	$490M	+19.4%	+47.5%	+68.7%	—	+126.1%	+30.0%	+186.7%
IOVAIovance Biotherapeutics, Inc.	$1.3B	+6.9%	+40.9%	+13.4%	—	-49.9%	-87.6%	-34.3%

Compare:IBIO vs IMVT IBIO vs ADMA IBIO vs HALO IBIO vs IMVT vs ADMA

About IBIO Dividend Returns

iBio, Inc. (IBIO) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of IBIO over the past year?

iBio, Inc. (IBIO) delivered a return of 92.94% over the past year. Since IBIO does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in IBIO be worth today?

A $10,000 investment in iBio, Inc. one year ago would be worth $19,294 today, representing a gain of $9,294.

Q3Does IBIO pay dividends?

iBio, Inc. (IBIO) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For IBIO, the total return equals the price-only return.

Q4Did IBIO beat the S&P 500?

Yes, iBio, Inc. (IBIO) outperformed the S&P 500 by 62.57 percentage points over the past year. IBIO delivered a total return of 92.94%, compared to the S&P 500's 30.37%. This 62.57pp alpha means investors in IBIO earned more than a passive S&P 500 index fund.

Q5What is IBIO's worst drawdown?

iBio, Inc. (IBIO) experienced a maximum drawdown of -48.21% over the past year, declining from its peak on 2026-02-26 to its trough on 2026-05-04. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is IBIO's long-term total return over 10, 20, or 30 years?

Here are iBio, Inc. (IBIO)'s long-term returns with dividends reinvested. Over 10 years, the total return is -100.0% (-53.5% CAGR) — $10,000 would have grown to $5. Over 20 years: -100.0% total return (-32.9% CAGR) — $10,000 → $3. Over 30 years: -100.0% total return (-23.3% CAGR) — $10,000 → $3. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was IBIO's best and worst year?

iBio, Inc.'s best calendar year was 2009 with a total return of 650.0%. Its worst year was 2022 with a total return of -97.1%. This range shows the volatility investors should expect — the difference between the best and worst year is 747.1 percentage points.